Literature DB >> 31113240

Analysis: Investigating the quality of POCT devices for HbA1c, what are our next steps?

Erna Lenters-Westra1,2, Emma English3.   

Abstract

There are a growing number of publications evaluating the performance of HbA1c point-of-care testing (POCT) devices when compared to routine laboratory instruments, but is this what we need from future studies? Here we describe the current understanding of the performance of POCT for HbA1c, which areas need further studies, and the key requirements for future publications based on performance evaluations of these devices. These include studies in clinical settings, performance measured against internationally standardized reference methods, and the need to evaluate new to the market devices that do not currently have a detailed performance history. In addition we highlight the need for external quality assessment schemes that are designed to support POCT in a wide range of clinical settings.

Keywords:  HbA1c; diabetes; point of care

Year:  2019        PMID: 31113240      PMCID: PMC6835179          DOI: 10.1177/1932296819850838

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  21 in total

1.  Diagnosing diabetes mellitus: performance of hemoglobin A1c point-of-care instruments in general practice offices.

Authors:  Una Ørvim Sølvik; Thomas Røraas; Nina Gade Christensen; Sverre Sandberg
Journal:  Clin Chem       Date:  2013-08-19       Impact factor: 8.327

2.  Fingerstick Precision and Total Error of a Point-of-Care HbA1c Test.

Authors:  William D Arnold; Kenneth Kupfer; Monica Hvidsten Swensen; Kyle S Fortner; Harold E Bays; Mathew Davis; Leslie J Klaff; Richard C San George
Journal:  J Diabetes Sci Technol       Date:  2019-03-06

3.  Accuracy of a Point-of-Care Hemoglobin A1c Assay.

Authors:  David M Nathan; Amanda Griffin; Francesca M Perez; Erica Basque; Lily Do; Barbara Steiner
Journal:  J Diabetes Sci Technol       Date:  2019-04-03

4.  Evaluation of 3 Hemoglobin A1c Point of Care Instruments. Point of Care Testing for HbA1c: Evaluation of Cobas b101, B-Analyst and Afinion™.

Authors:  María De Toro-Crespo; Catalina Sánchez-Mora; Patricia Fernández-Riejos; José M Maesa-Márquez; Concepción González-Rodríguez
Journal:  Clin Lab       Date:  2017-07-01       Impact factor: 1.138

5.  EurA1c: The European HbA1c Trial to Investigate the Performance of HbA1c Assays in 2166 Laboratories across 17 Countries and 24 Manufacturers by Use of the IFCC Model for Quality Targets.

Authors: 
Journal:  Clin Chem       Date:  2018-06-19       Impact factor: 8.327

6.  Evaluation of Three Hemoglobin A1c Point-of-Care Instruments.

Authors:  Marieke Criel; Stijn Jonckheere; Michel Langlois
Journal:  Clin Lab       Date:  2016       Impact factor: 1.138

7.  2010 consensus statement on the worldwide standardization of the hemoglobin A1C measurement.

Authors:  Ragnar Hanas; Garry John
Journal:  Diabetes Care       Date:  2010-06-02       Impact factor: 19.112

8.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

Authors:  D M Nathan; S Genuth; J Lachin; P Cleary; O Crofford; M Davis; L Rand; C Siebert
Journal:  N Engl J Med       Date:  1993-09-30       Impact factor: 91.245

9.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

10.  Long-Term Performance of Point-of-Care Hemoglobin A1c Assays.

Authors:  Sujaytha Paknikar; Rohan Sarmah; Losika Sivaganeshan; Adam Welke; Al Rizzo; Kirk Larson; Marc Rendell
Journal:  J Diabetes Sci Technol       Date:  2016-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.